BioSpace News Archive

Cleerly ® Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System.

Novel Bio announced today that they have formed a partnership with Culture Biosciences to accelerate the development of scalable fermentation processes for their proprietary NBx Platform ™ for plasmid DNA production.

Morningstar, Inc. today announced that the Intelligent Medicine Exchange (“IMX”), the first futures and options exchange focused on the healthcare economy, has aligned with Morningstar Indexes to offer its first futures product.

Lexaria Bioscience Corp. announces details of an 8-week animal study WEIGHT-A24-1 (the “Study”) to examine diabetes and weight loss effects of DehydraTECH-processed glucagon-like peptide 1 (“GLP-1") drugs and DehydraTECH-processed cannabidiol, alone and in combination.

CurvaFix, Inc ., a developer of medical devices that deliver stable fixation for curved anatomy and poor bone quality, announced today the appointment of J. Kurt Jacobus, Ph.D., as the newest member of its Board of Directors.

MyMD Pharmaceuticals, Inc. today announced that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) on March 4, 2024 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (“Listing Rule”).

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, announced its new AL Amyloidosis awareness campaign Be Proactive in AL™.

GenScript Biotech Corporation, a global leader in life science research tools and services, is pleased to announce the expansion of their collaboration with Roche.

Pfizer Inc. (NYSE: PFE) invites investors and the general public listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer & President, Pfizer Research and Development, at the Leerink Partners Global Biopharma Conference 2024 on Tuesday, March 12, 2024 at 8:00 a.m. Eastern Daylight Time.

B. Braun Medical Inc., a leader in smart infusion therapy and pain management, announced a collaboration agreement with Orlando Health, a nationally recognized healthcare provider with award-winning hospitals, to jointly develop innovative solutions to increase access to care for patients and clinicians.